(NBIX) Neurocrine Biosciences complete technical analysis [charts+indicators] | Buy/Sell Neurocrine Biosciences | (NBIX) share price targets
Complete technical analysis of Neurocrine Biosciences (NBIX) by charts plus indicators, forecast predictions and share price targets for Neurocrine Biosciences (NBIX)
Neurocrine Biosciences trades in USA in Health Care sector.
10 day averaged volume of Neurocrine Biosciences is 1314080
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Mon Mar 2025 | 114.48 | 118.65 | 119.00 | 114.29 | 1.145 times |
| 28 Fri Feb 2025 | 118.72 | 117.27 | 118.93 | 116.83 | 1.047 times |
| 27 Thu Feb 2025 | 117.51 | 117.40 | 117.85 | 115.83 | 1.046 times |
| 26 Wed Feb 2025 | 117.59 | 116.45 | 118.71 | 116.00 | 0.678 times |
| 25 Tue Feb 2025 | 115.90 | 118.60 | 120.00 | 115.20 | 1.194 times |
| 24 Mon Feb 2025 | 119.11 | 120.53 | 120.80 | 118.66 | 1.032 times |
| 21 Fri Feb 2025 | 120.69 | 121.05 | 122.37 | 118.57 | 1.492 times |
| 20 Thu Feb 2025 | 116.11 | 115.05 | 117.68 | 114.00 | 0.9 times |
| 19 Wed Feb 2025 | 114.26 | 113.56 | 114.93 | 113.00 | 0.744 times |
| 18 Tue Feb 2025 | 113.97 | 115.02 | 115.82 | 113.02 | 0.742 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 110.3 as stoploss in an intra day buy trade for a target of 124. However, stock will show a bearish move below 110.3.
Share price targets for Neurocrine Biosciences (NBIX)
| Target Type | Value |
| Downside Target | 113.00 |
| Upside Target | 119.00 |
| Upside Target | 122.37 |
| Upside Target | 125.61 |
| Upside Target | 125.93 |
| Upside Target | 129.67 |
| Upside Target | 136.13 |
| Upside Target | 140.00 |
| Upside Target | 153.88 |
| Upside Target | 154.61 |
Intraday share price targets for Neurocrine Biosciences (NBIX)
| Target Type | Value |
| Downside Intraday Target | 112.85 |
| Downside Intraday Target | 111.21 |
| Upside Intraday Target | 117.56 |
| Upside Intraday Target | 120.63 |
| Upside Intraday Target | 115.92 |
Weekly technical analysis of Neurocrine Biosciences (NBIX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Mon Mar 2025 | 114.48 | 118.65 | 119.00 | 114.29 | 0.229 times |
| 28 Fri Feb 2025 | 118.72 | 120.53 | 120.80 | 115.20 | 1.288 times |
| 21 Fri Feb 2025 | 120.69 | 115.02 | 122.37 | 113.00 | 0.493 times |
| 14 Fri Feb 2025 | 115.02 | 123.51 | 125.93 | 113.79 | 0.944 times |
| 07 Fri Feb 2025 | 122.62 | 149.29 | 153.88 | 119.76 | 2.128 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Neurocrine Biosciences (NBIX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Mon Mar 2025 | 114.48 | 118.65 | 119.00 | 114.29 | 0.046 times |
| 28 Fri Feb 2025 | 118.72 | 149.29 | 153.88 | 113.00 | 1.563 times |
| 31 Fri Jan 2025 | 151.82 | 137.07 | 154.61 | 136.13 | 1.274 times |
| 31 Tue Dec 2024 | 136.50 | 128.33 | 140.00 | 125.61 | 0.828 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Neurocrine Biosciences (NBIX)
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Neurocrine Biosciences in short term and the sell signal is strong.
Neurocrine Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 117.11 and Neurocrine Biosciences (NBIX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Neurocrine Biosciences (NBIX) stock. Volume based technical analysis of Neurocrine Biosciences (NBIX) stock is negative.
Neurocrine Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Neurocrine Biosciences ( (NBIX) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Neurocrine Biosciences in short term and the sell signal is strong.
Neurocrine Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 117.11 and Neurocrine Biosciences (NBIX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Neurocrine Biosciences (NBIX) stock. Volume based technical analysis of Neurocrine Biosciences (NBIX) stock is negative.
Neurocrine Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.